Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice


Creative Commons License

Spelman T., Meyniel C., Ignacio Rojas J., Lugaresi A., Izquierdo G., Grand'Maison F., ...More

MULTIPLE SCLEROSIS JOURNAL, vol.23, no.10, pp.1346-1357, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 10
  • Publication Date: 2017
  • Doi Number: 10.1177/1352458516679893
  • Title of Journal : MULTIPLE SCLEROSIS JOURNAL
  • Page Numbers: pp.1346-1357
  • Keywords: Nomogram, clinically isolated syndrome, clinically definite multiple sclerosis, second attack, disease-modifying drugs, MRI, CSF, MS, CIS, MULTIPLE-SCLEROSIS, DIAGNOSTIC-CRITERIA, CEREBROSPINAL-FLUID, INTERFERON BETA-1A, OLIGOCLONAL BANDS, MRI CRITERIA, CONVERSION, DISABILITY, ATTACKS

Abstract

Background: Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient at highest risk of early second attack and could benefit the most from early disease-modifying drugs (DMDs).